Molecular mechanisms of viral immune evasion proteins to inhibit MHC class i antigen processing and presentation

International Reviews of Immunology

Volumn 28, Issue 5, 2009, Pages 376-393

  Zhou, Fang ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

CTL epitope; IFN ; IRF 1; JAK STAT signal transduction pathway; MHC class I antigen presentation; viral immune evasion protein

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOVIRUS E19 PROTEIN; AMINO ACID; DERLIN 1; DOUBLE STRANDED RNA; EPITOPE; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; ICP47 PROTEIN; INITIATION FACTOR 2; JANUS KINASE 1; JANUS KINASE 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NONSTRUCTURAL PROTEIN 1; PROTEIN E7; PROTEIN KINASE R; PROTEIN P97; PROTEIN U21; STAT1 PROTEIN; TRANSPORTER ASSOCIATED ANTIGEN PROCESSING 1; TRANSPORTER ASSOCIATED ANTIGEN PROCESSING 2; UL49.5 PROTEIN; UNCLASSIFIED DRUG; UNIQUE SHORT TERM PROTEIN 11; UNIQUE SHORT TERM PROTEIN 2; UNIQUE SHORT TERM PROTEIN 6; VCP INTERACTING MEMBRANE PROTEIN; VIRAL IMMUNE EVASION PROTEIN; VIRUS ANTIGEN; VIRUS PROTEIN; HLA ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; ENZYME INACTIVATION; HERPES VIRUS; HOST CELL; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; INHIBITION KINETICS; KAPOSI SARCOMA ASSOCIATED HERPES VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MURINE HERPES VIRUS 68; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; IMMUNOLOGY;

ANIMALS; ANTIGEN PRESENTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNE EVASION; SIGNAL TRANSDUCTION; VIRAL PROTEINS;

EID: 73349128425     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.1080/08830180903013034     Document Type: Review

References (121)

1. B.N. Lilley and H.L. Ploeghm, Viral modulation of antigen presentation: Manipulation of cellular targets in the ER and beyond. Immunol Rev 207: 126-144, 2005. (Pubitemid 41415013)
2. J.W. Yewdell and J.R. Bennink, Mechanisms of viral interference with MHC class I antigen processing and presentation. Annu Rev Cell Dev Biol 15: 579-606, 1999. (Pubitemid 32250387)
3. E.S. Trombetta and I. Mellman, Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 23: 975-1028, 2005. (Pubitemid 40563191)
4. R. Abele and R. Tampe, Modulation of the antigen transport machinery TAP by friends and enemies. FEBS Lett 580: 1156-1163, 2006. (Pubitemid 43186039)
5. M.N. Wrightham, J.P. Stewart, N.J. Janjua, S.D. Pepper, C. Sample, C.M. Rooney, and J.R. Arrand, Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1. Virology 208: 521-530, 1995.
6. J.M. Boname and P.G. Stevenson, MHC class I ubiquitination by a viral PHD/LAP finger protein. Immunity 15: 627-636, 2001. (Pubitemid 33016447)
7. A. Hill, P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, et al., Herpes simplex virus turns off the TAP to evade host immunity. Nature 375: 411-415, 1995.
8. R. Tomazin, A.B. Hill, P. Jugovic, I. York, P. van Endert, H.L. Ploegh, et al., Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J 15: 3256-3266, 1996. (Pubitemid 26231931)
9. K. Ahn, T.H. Meyer, S. Uebel, P. Sempe, H. Djaballah, Y. Yang, et al., Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J 15: 3247-3255, 1996. (Pubitemid 26231930)
10. K. Fruh, K. Ahn, H. Djaballah, P. Sempe, P.M. van Endert, R. Tampe, et al., A viral inhibitor of peptide transporters for antigen presentation. Nature 375: 415-418, 1995.
11. C. Kyritsis, S. Gorbulev, S. Hutschenreiter, K. Pawlitschko, R. Abele, and R. Tampe, Molecular mechanism and structural aspects of transporter associated with antigen processing inhibition by the cytomegalovirus protein US6. J Biol Chem 276: 48031-48039, 2001.
12. P.J. Lehner, J.T. Karttunen, G.W. Wilkinson, and P. Cresswell, The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc Natl Acad Sci U S A 94: 6904-6909, 1997. (Pubitemid 27281963)
13. H. Hengel, J.O. Koopmann, T. Flohr, W. Muranyi, E. Goulmy, G.J. Hammerling, et al., A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6: 623-632, 1997. (Pubitemid 27239353)
14. A.L. Ackerman, C. Kyritsis, R. Tampe, and P. Cresswell, Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc Natl Acad Sci U S A 100: 12889-12894, 2003. (Pubitemid 37339995)
15. S. Burgdorf, C. Scholz, A. Kautz,R. Tampe, and C. Kurts, Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat Immunol 9: 558-566, 2008. (Pubitemid 351560525)
16. A.D. Lipinska, D. Koppers-Lalic, M. Rychlowski, P. Admiraal, F.A. Rijsewijk, K. Bienkowska-Szewczyk, and E.J. Wiertz, Bovine herpesvirus 1 UL49.5 protein inhibits the transporter associated with antigen processing despite complex formation with glycoprotein M. J Virol 80: 5822-5832, 2006. (Pubitemid 43849160)
17. M.C. Verweij, D. Koppers-Lalic, S. Loch, F. Klauschies, H. de la Salle, E. Quinten, P.J. Lehner, et al., The varicellovirus UL49.5 protein blocks the transporter associated with antigen processing (TAP) by inhibiting essential conformational transitions in the 6+6 transmembrane TAP core complex. J Immunol 181: 4894-4907, 2008.
18. S. Loch, F. Klauschies, C. Scholz, M.C. Verweij, E.J.Wiertz, J. Koch, and R. Tampe, Signaling of a varicelloviral factor across the endoplasmic reticulum membrane induces destruction of the peptide-loading complex and immune evasion. J Biol Chem 283: 13428-13436, 2008.
19. E.M. Bennett, J.R. Bennink, J.W. Yewdell, F.M. and Brodsky, Cutting edge: Adenovirus E19 has two mechanisms for affecting class I MHC expression. J Immunol 162: 5049-5052, 1999. (Pubitemid 29307102)
20. D.C. Beier, J.H. Cox, D.R. Vining, P. Cresswell, and V.H. Engelhard, Association of human class I MHC alleles with the adenovirus E3/19K protein. J Immunol 152: 3862-3872, 1994. (Pubitemid 24111058)
21. N.T. Pande, C. Powers, K. Ahn, and K. Fruh, Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11. J Virol 79: 5786-5798, 2005. (Pubitemid 40548247)
22. G.H. Ashrafi, M.R. Haghshenas, B. Marchetti, P.M. O'Brien, and M.S. Campo, E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. Int J Cancer 113: 276-283, 2005. (Pubitemid 39628318)
23. G.H. Ashrafi, E. Tsirimonaki, B. Marchetti, P.M. O'Brien, G.J. Sibbet, L. Andrew, and M.S. Campo, Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene 21: 248-259, 2002. (Pubitemid 34102133)
24. B. Marchetti, G.H. Ashrafi, E. Tsirimonaki, P.M. O'Brien, and M.S. Campo, The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface. Oncogene 21: 7808-7816, 2002. (Pubitemid 35398838)
25. J.I. Cohen, Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocompatibility complex antigens. J Infect Dis 177: 1390-1393, 1998. (Pubitemid 28194285)
26. A. Abendroth and A. Arvin, Varicella-zoster virus immune evasion. Immunol Rev 168: 143-156, 1999. (Pubitemid 29276679)
27. A.W. Hudson, D. Blom, P.M. Howley, and H.L. Ploegh, The ER-lumenal domain of the HHV-7 immunoevasin U21 directs class I MHC molecules to lysosomes. Traffic 4: 824-837, 2003. (Pubitemid 37540586)
28. J. Binette and E.A. Cohen, Recent advances in the understanding of HIV-1 Vpu accessory protein functions. Curr Drug Targets Immune Endocr Metabol Disord 4: 297-307, 2004. (Pubitemid 39445427)
29. T. Luo, J.L. Foster, and J.V. Garcia, Molecular determinants of Nef function. J Biomed Sci 4: 132-138, 1997. (Pubitemid 27374998)
30. M.E. Lorenzo, J.U. Jung, and H.L. Ploegh, Kaposi's sarcoma-associated herpesvirus K3 utilizes the ubiquitin-proteasome system in routing class major histocompatibility complexes to late endocytic compartments. J Virol 76: 5522-5531, 2002. (Pubitemid 34517902)
31. S. Ishido, C. Wang, B.S. Lee, G.B. Cohen, and J.U. Jung, Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 74: 5300-5309, 2000. (Pubitemid 30313872)
32. E. Bartee, M. Mansouri, B.T. Hovey Nerenberg, K. Gouveia, and K. Fruh, Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J Virol 78: 1109-1120, 2004. (Pubitemid 38095821)
33. S. Ishido, J.K. Choi, B.S. Lee, C. Wang, M. DeMaria, R.P. Johnson, et al., Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity 13: 365-374, 2000.
34. K. Fruh, E. Bartee, K. Gouveia, andM.Mansouri, Immune evasion by a novel family of viral PHD/LAP-finger proteins of gamma-2 herpesviruses and poxviruses. Virus Res 88: 55-69, 2002. (Pubitemid 35251899)
35. M. Mansouri, E. Bartee, K. Gouveia, B.T. Hovey Nerenberg, J. Barrett, L. Thomas, et al., The PHD/LAP-domain protein M153R of myxomavirus is a ubiquitin ligase that induces the rapid internalization and lysosomal destruction of CD4. J Virol 77: 1427-1440, 2003. (Pubitemid 36055564)
36. M. Chen and D. Gerlier, Viral hijacking of cellular ubiquitination pathways as an anti-innate immunity strategy. Viral Immunol 19: 349-362, 2006. (Pubitemid 44735049)
37. K. Newton, M.L. Matsumoto, I.E. Wertz, D.S. Kirkpatrick, J.R. Lill, and J. Tan. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell 134: 668-678, 2008.
38. W.J. Cook, L.C. Jeffrey, M. Carson, Z. Chen, and C.M. Pickart, Structure of a diubiquitin conjugate and a model for interaction with ubiquitin conjugating enzyme (E2). J Biol Chem267: 16467-16471, 1992.
39. R. Varadan, M. Assfalg, A. Haririnia, S. Raasi, C. Pickart, and D. Fushman, Solution conformation of Lys63-linked di-ubiquitin chain provides clues to functional diversity of polyubiquitin signaling. J Biol Chem 279: 7055-7063, 2004. (Pubitemid 38248851)
40. V. Chau, J.W. Tobias, A. Bachmair, D. Marriott, D.J. Ecker, D.K. Gonda, and A. Varshavsky, A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 243: 1576-1583, 1989. (Pubitemid 19090506)
41. A. Adhikari, M. Xu, and Z.J. Chen, Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 26: 3214-3226, 2007. (Pubitemid 46763016)
42. L. Sun and Z.J. Chen, The novel functions of ubiquitination in signaling. Curr Opin Cell Biol 16: 119-126, 2004. (Pubitemid 38757287)
43. P.J. Lehner and P. Cresswell, Recent developments in MHC-class-I-mediated antigen presentation. Curr Opin Immunol 16: 82-89, 2004. (Pubitemid 38198121)
44. J.M. Boname, J.S. May, and P.G. Stevenson, The murine gamma-herpesvirus-68 MK3 protein causes TAP degradation independent of MHC class I heavy chain degradation. Eur J Immunol 35: 171-179, 2005. (Pubitemid 40123863)
45. X. Wang, L. Lybarger, R. Connors, M.R. Harris, and T.H. Hansen, Model for the interaction of gammaherpesvirus 68 RING-CH finger protein mK3 with major histocompatibility complex class I and the peptide-loading complex. J Virol 78: 8673-8686, 2004. (Pubitemid 39025133)
46. J.M. Boname, B.D. de Lima, P.J. Lehner, and P.G. Stevenson, Viral degradation of the MHC class I peptide loading complex. Immunity 20: 305-317, 2004. (Pubitemid 38388232)
47. L. Lybarger, X. Wang, M.R. Harris, H.W.T. Virgin, and T.H. Hansen, Virus subversion of the MHC class I peptide-loading complex. Immunity 18: 121-130, 2003. (Pubitemid 36120693)
48. E. Paulson, C. Tran, K. Collins, and K. Fruh, KSHV-K5 inhibits phosphorylation of the major histocompatibility complex class I cytoplasmic tail. Virology 288: 369-378, 2001. (Pubitemid 32929916)
49. R.E. Means, S. Ishido, X. Alvarez, and J.U. Jung, Multiple endocytic trafficking pathways of MHC class I molecules induced by a herpesvirus protein. Embo J 21: 1638-1649, 2002. (Pubitemid 34614620)
50. M. Yamamoto, T. Okamoto, K. Takeda, S. Sato, H. Sanjo, S. Uematsu, et al., Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nat Immunol 7: 962-970, 2006. (Pubitemid 44263910)
51. M.J. Lewis, L.F. Saltibus, D.D. Hau, W. Xiao, and L. Spyracopoulos, Structural basis for non-covalent interaction between ubiquitin and the ubiquitin conjugating enzyme variant human MMS2. J Biomol NMR 34: 89-100, 2006.
52. W. Zou, V. Papov, O. Malakhova, K.I. Kim, C. Dao, J. Li, and D.E. Zhang, ISG15 modification of ubiquitin E2 Ubc13 disrupts its ability to form thioester bond with ubiquitin. Biochem Biophys Res Commun 336: 61-68, 2005. (Pubitemid 41253403)
53. J.L. Murk, W. Stoorvogel, M.J. Kleijmeer, and H.J. Geuze, The plasticity of multivesicular bodies and the regulation of antigen presentation. Semin Cell Dev Biol 13: 303-311, 2002. (Pubitemid 35304516)
54. J. Hirst and M.S. Robinson, Clathrin and adaptors. Biochim Biophys Acta 1404: 173-193, 1998. (Pubitemid 28375715)
55. V. Winter and M.T. Hauser, Exploring the ESCRTing machinery in eukaryotes. Trends Plant Sci 11: 115-123, 2006. (Pubitemid 43376141)
56. K.G. Bache, A. Brech, A. Mehlum, and H. Stenmark, Hrs regulates multivesicular body formation via ESCRT recruitment to endosomes. J Cell Biol 162: 435-442, 2003. (Pubitemid 36988552)
57. M.J. Clague and S. Urbe, Hrs function: Viruses provide the clue. Trends Cell Biol 13: 603-606, 2003. (Pubitemid 37415023)
58. P.G. Stevenson, J.M. Boname, B. de Lima, and S. Efstathiou, A battle for survival: Immune control and immune evasion in murine gamma-herpesvirus-68 infection. Microbes Infect 4: 1177-1182, 2002. (Pubitemid 35279525)
59. P.C. Doherty, J.P. Christensen, G.T. Belz, P.G. Stevenson, and M.Y. Sangster, Dissecting the host response to a gamma-herpesvirus. Philos Trans R Soc Lond B Biol Sci 356: 581-593, 2001.
60. P.G. Stevenson, S. Efstathiou, P.C. Doherty, and P.J. Lehner, Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc Natl Acad Sci U S A 97: 8455-8460, 2000. (Pubitemid 30639694)
61. P.G. Stevenson, J.S. May, X.G. Smith, S. Marques, H. Adler, U.H. Koszinowski, et al., K3-mediated evasion of CD8(+) T cells aids amplification of a latent gammaherpesvirus. Nat Immunol 3: 733-740, 2002.
62. L.M. Duncan, S. Piper, R.B.Dodd, M.K. Saville, C.M. Sanderson, J.P. Luzio, and P.J. Lehner, Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules. Embo J 25: 1635-1645, 2006.
63. V. Piguet, O. Schwartz, S. Le Gall, and D. Trono, The downregulation of CD4 and MHC-I by primate lentiviruses: A paradigm for the modulation of cell surface receptors. Immunol Rev 168: 51-63, 1999. (Pubitemid 29276672)
64. R.S. Polishchuk, E. San Pietro, A. Di Pentima, S. Tete, and J.S. Bonifacino, Ultrastructure of long-range transport carriers moving from the trans Golgi network to peripheral endosomes. Traffic 7: 1092-1103, 2006.
65. M.S. Robinson and J.S. Bonifacino, Adaptor-related proteins. Curr Opin Cell Biol 13: 444-453, 2001. (Pubitemid 32709768)
66. M. Teuchert, W. Schafer, S. Berghofer, B. Hoflack, H.D. Klenk, and W. Garten, Sorting of furin at the trans-Golgi network. Interaction of the cytoplasmic tail sorting signals with AP-1 Golgi-specific assembly proteins.J Biol Chem 274: 8199-8207, 1999.
67. J.F. Roeth, M. Williams, M.R. Kasper, T.M. Filzen, and K.L. Collins, HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail. J Cell Biol 167: 903-913, 2004. (Pubitemid 39628112)
68. M. del Val, H. Hengel, H. Hacker, U. Hartlaub, T. Ruppert, P. Lucin, and U.H. Koszinowski, Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J Exp Med 176: 729-738, 1992.
69. H. Hengel, P. Lucin, S. Jonjic, T. Ruppert, and U.H. Koszinowski, Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape. J Virol 68: 289-297, 1994.
70. R. Holtappels, N.K. Grzimek, C.O. Simon, D. Thomas, D. Dreis, and M.J. Reddehase, Processing and presentation of murine cytomegalovirus pORFm164-derived peptide in fibroblasts in the face of all viral immunosubversive early gene functions. J Virol 76: 6044-6053, 2002. (Pubitemid 34556299)
71. R. Holtappels, D. Gillert-Marien, D. Thomas, J. Podlech, P. Deegen, S. Herter, et al., Cytomegalovirus encodes a positive regulator of antigen presentation.J Virol 80: 7613-7624, 2006. (Pubitemid 44092582)
72. M. Wagner, A. Gutermann, J. Podlech, M.J. Reddehase, and U.H. Koszinowski, Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus.J Exp Med 196: 805-816, 2002.
73. H. Hengel, U. Reusch, G. Geginat, R. Holtappels, T. Ruppert, E. Hellebrand, and U.H.Koszinowski, Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus. J Virol 74: 7861-7868, 2000. (Pubitemid 30641629)
74. M.T. Barel, G.C. Hassink, S. van Voorden, and E.J. Wiertz, Human cytomegalovirus-encoded US2 and US11 target unassembled MHC class I heavy chains for degradation. Mol Immunol 43: 1258-1266, 2006. (Pubitemid 43063178)
75. C.E. Shamu, C.M. Story, T.A. Rapoport, and H.L. Ploegh, The pathway of US11-dependent degradation of MHC class I heavy chains involves a ubiquitinconjugated intermediate. J Cell Biol 147: 45-58, 1999.
76. V. Vittone, E. Diefenbach, D. Triffett, M.W. Douglas, A.L. Cunningham, and R.J. Diefenbach, Determination of interactions between tegument proteins of herpes simplex virus type 1. J Virol 79: 9566-9571, 2005. (Pubitemid 41022299)
77. Y. Ye, Y. Shibata, C. Yun, D. Ron, and T.A. Rapoport, A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429: 841-847, 2004. (Pubitemid 38843292)
78. T.J. Radosevich, T. Seregina, and C.J. Link, Effective suppression of class I major histocompatibility complex expression by the US11 or ICP47 genes can be limited by cell type or interferon-gamma exposure. Hum Gene Ther 14: 1765-1775, 2003. (Pubitemid 38010666)
79. E. Fiebiger, C. Story, H.L. Ploegh, and D. Tortorella, Visualization of the ER-tocytosol dislocation reaction of a type I membrane protein. Embo J 21: 1041-1053, 2002. (Pubitemid 34206177)
80. H. Hengel, T. Flohr, G.J. Hammerling, U.H. Koszinowski, and F.Momburg, Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly. J Gen Virol 77: 2287-2296, 1996. (Pubitemid 26316100)
81. B.N. Lilley and H.L. Ploegh, A membrane protein required for dislocation of misfolded proteins from the ER.Nature 429: 834-840, 2004. (Pubitemid 38843291)
82. S. Loch and R. Tampe, Viral evasion of the MHC class I antigen-processing machinery. Pflugers Arch 451: 409-417, 2005. (Pubitemid 41719572)
83. U. Boehm, T. Klamp, M. Groot, and J.C. Howard, Cellular responses to interferongamma. Annu Rev Immunol 15: 749-795, 1997.
84. T.E. Morrison, A. Mauser, A. Wong, J.P. Ting, and S.C. Kenney, Inhibition of IFNgamma signaling by an Epstein-Barr virus immediate-early protein. Immunity 15: 787-799, 2001. (Pubitemid 34008506)
85. B. Barnes, B. Lubyova, and P.M. Pitha, On the role of IRF in host defense. J Interferon Cytokine Res 22: 59-71, 2002. (Pubitemid 34161283)
86. S. Fuld, C. Cunningham, K. Klucher, A.J. Davison, and D.J. Blackbourn, Inhibition of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein. J Virol 80: 3092-3097, 2006. (Pubitemid 43346406)
87. M. Paulson, S. Pisharody, L. Pan, S. Guadagno, A.L. Mui, and D.E. Levy, Stat protein transactivation domains recruit p300/CBP through widely divergent sequences. J Biol Chem 274: 25343-25349, 1999.
88. B. Gotoh, T. Komatsu, K. Takeuchi, and J. Yokoo, The C-terminal half-fragment of the Sendai virus C protein prevents the gamma-activated factor from binding to a gamma-activated sequence site. Virology 316: 29-40, 2003. (Pubitemid 37346306)
89. L.H. Malkas, R.J. Hickey, C. Li, N. Pedersen, and E.F. Baril, A 21S enzyme complex from HeLa cells that functions in simian virus 40 DNA replication in vitro. Biochemistry 29: 6362-6374, 1990. (Pubitemid 20210785)
90. Y. Ishimi, A. Claude, P. Bullock, and J. Hurwitz, Complete enzymatic synthesis of DNA containing the SV40 origin of replication. J Biol Chem 263: 19723-19733, 1988. (Pubitemid 19016456)
91. G. Gribaudo, D. Lembo, G. Cavallo, S. Landolfo, and P. Lengyel, Interferon action: binding of viral RNA to the 40-kilodalton 2′-5′-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus. J Virol 65: 1748-1757, 1991.
92. W. Yuan, J.M. Aramini, G.T. Montelione, and R.M. Krug, Structural basis for ubiquitin-like ISG 15 protein binding to the NS1 protein of influenza B virus: A protein-protein interaction function that is not shared by the corresponding N-terminal domain of the NS1 protein of influenza A virus. Virology 304: 291-301, 2002. (Pubitemid 36069170)
93. W. Yuan and R.M. Krug, Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. Embo J 20: 362-371, 2001. (Pubitemid 32126972)
94. G.S. Taylor, and A.B. Rickinson, Antigens and Autophagy: The Path Less Travelled By? Autophagy 3: 60-62, 2007. (Pubitemid 46100717)
95. Y. Ben-Asouli, Y. Banai, Y. Pel-Or, A. Shir, and R. Kaempfer. Human interferongamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR. Cell 108: 221-232, 2002. (Pubitemid 34161142)
96. A.H.Wong, J.E. Durbin, S. Li, T.E. Dever, T. Decker, and A.E. Koromilas, Enhanced antiviral and antiproliferative properties of a STAT1 mutant unable to interact with the protein kinase PKR. J Biol Chem 276: 13727-13737, 2001.
97. Q. Pang,W. Keeble, J. Diaz, T.A. Christianson, S. Fagerlie, K. Rathbun, et al., Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon gamma, tumor necrosis factor-alpha, and double-stranded RNA. Blood 97: 1644-1652, 2001. (Pubitemid 32217229)
98. A.E. Koromilas, C. Cantin, A.W. Craig, R. Jagus, J. Hiscott, and N. Sonenberg, The interferon-inducible protein kinase PKR modulates the transcriptional activation of immunoglobulin kappa gene. J Biol Chem 270: 25426-25434, 1995.
99. J. Gil andM. Esteban, The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors. Oncogene 19: 3665-3674, 2000. (Pubitemid 30608488)
100. H. Nakamura,M. Li, J. Zarycki, and J.U. Jung, Inhibition of p53 tumor suppressor by viral interferon regulatory factor. J Virol 75: 7572-7582, 2001. (Pubitemid 32738015)
101. F. Baran-Marszak, J. Feuillard, I.Najjar, C. Le Clorennec, J.M. Bechet, I.Dusanter- Fourt, et al., Differential roles of STAT1alpha and STAT1beta in fludarabineinduced cell cycle arrest and apoptosis in human B cells. Blood 104: 2475-2483, 2004. (Pubitemid 39331850)
102. G.N. Barber, Host defense, viruses and apoptosis. Cell Death Differ 8: 113-126, 2001. (Pubitemid 32201359)
103. A.K. Lo, K.W. Lo, S.W. Tsao, H.L. Wong, J.W. Hui, K.F. To, et al., Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Neoplasia 8: 173-180, 2006. (Pubitemid 43671232)
104. M.A. Watanabe, L.R. de Souza, J.M. Murad, and F.L. De Lucca, Activation of the RNA-dependent protein kinase (PKR) of lymphocytes by regulatory RNAs: Implications for immunomodulation in HIV infection. Curr HIV Res 3: 329-337, 2005. (Pubitemid 41644874)
105. R. Cai, B. Carpick, R.F. Chun, K.T. Jeang, and B.R. Williams, HIV-I TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms. Arch Biochem Biophys 373: 361-367, 2000. (Pubitemid 30068974)
106. T.G. Lee, N. Tang, S. Thompson, J. Miller, and M.G. Katze, The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins. Mol Cell Biol 14: 2331-2342, 1994.
107. B.R.Williams, PKR: A sentinel kinase for cellular stress. Oncogene 18: 6112-6120, 1999.
108. M. Mulvey, J. Poppers, D. Sternberg, and I. Mohr, Regulation of eIF2alpha phosphorylation by different functions that act during discrete phases in the herpes simplex virus type 1 life cycle. J Virol 77: 10917-10928, 2003. (Pubitemid 37204285)
109. I. Mohr, Neutralizing innate host defenses to control viral translation in HSV-1 infected cells. Int Rev Immunol 23: 199-220, 2004. (Pubitemid 38121753)
110. S. Gunnery and M.B. Mathews, RNA binding and modulation of PKR activity. Methods 15: 189-198, 1998.
111. M. Mulvey, J. Poppers, A. Ladd, and I. Mohr, A herpesvirus ribosome-associated, RNA-binding protein confers a growth advantage upon mutants deficient in a GADD34-related function. J Virol 73: 3375-3385, 1999. (Pubitemid 29135731)
112. S. Li, S. Labrecque, M.C. Gauzzi, A.R. Cuddihy, A.H.Wong, S. Pellegrini, et al., The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 18: 5727-5737, 1999. (Pubitemid 29507426)
113. K. Zanier, S. Charbonnier, M. Baltzinger, Y. Nomine, D. Altschuh, and G. Trave, Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance. J Mol Biol 349: 401-412, 2005. (Pubitemid 40693758)
114. S.J. Um, J.W. Rhyu, E.J. Kim, K.C. Jeon, E.S. Hwang, and J.S. Park, Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo. Cancer Lett 179: 205-212, 2002.
115. J.S. Park, E.J. Kim, H.J. Kwon, E.S. Hwang, S.E. Namkoong, and S.J. Um, Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J Biol Chem 275: 6764-6769, 2000.
116. I. Nusinzon and C.M. Horvath, Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1. Proc Natl Acad Sci U S A 100: 14742-14747, 2003. (Pubitemid 37517961)
117. D.X. Nguyen, T.F.Westbrook, andD.J. McCance,Human papillomavirus type 16E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest. J Virol 76: 619-632, 2002. (Pubitemid 34033361)
118. N.T. Georgopoulos, J.L. Proffitt, and G.E. Blair, Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins. Oncogene 19: 4930-4935, 2000.
119. W.H. Kao, S.L. Beaudenon, A.L. Talis, J.M. Huibregtse, and P.M. Howley, Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitinprotein ligase. J Virol 74: 6408-6417, 2000. (Pubitemid 30429807)
120. T. Seo, D. Lee, B. Lee, J.H. Chung, and J. Choe, Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) binds to, and inhibits transactivation of, CREB-binding protein. Biochem Biophys Res Commun 270: 23-27, 2000. (Pubitemid 30440387)
121. B. Lubyova, M.J. Kellum, A.J. Frisancho, and P.M. Pitha, Kaposi's sarcomaassociated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7. J Biol Chem 279: 7643-7654, 2004. (Pubitemid 38294645)